PHARMENFORM
ActiveSummary
PHARMENFORM has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €234,833 and a net result of €54,895. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 55% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Directors
No directors read yet: 0 of 4 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.